IFN‐β can reduce the expression of SLC7A11 and SLC3A2 on the tumor cell membrane, disrupt the tumor cell's antioxidant system, and induce tumor cell ferroptosis [71, 88]. The gene discussed is SLC3A2; the disease is neoplasm.